⌘K
t
On 1 September 2025, ECO Animal Health Group plc appointed Panmure Liberum Limited as Joint Broker with immediate effect. Singer Capital Markets will remain as the Company's Nominated Adviser and Joint Broker.
| Date | 1 Sept 2025 |
| Time | 07:00:12 |
| Category | Corporate updates |
| ID | 2908X |
1 September 2025
ECO Animal Health Group plc
(''ECO" or the "Company")
Appointment of Joint Broker
ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces the appointment of Panmure Liberum Limited ("Panmure Liberum") as Joint Broker to the Company with immediate effect. Singer Capital Markets will remain as the Company's Nominated Adviser and Joint Broker.
-Ends-
Contacts
|
ECO Animal Health Group plc David Hallas (Chief Executive Officer) Christopher Wilks (Chief Financial Officer)
|
|
|
ICR Healthcare (Financial PR) Mary-Jane Elliott Jessica Hodgson
|
020 3709 5700
|
|
Singer Capital Markets (Nominated Adviser & Joint Broker) Philip Davies Sam Butcher
|
020 7496 3000 |
|
Panmure Liberum (Joint Broker) Emma Earl Will Goode Mark Rogers Rupert Dearden
|
020 3100 2000
|
|
Equity Development Hannah Crowe Matt Evans |
020 7065 2692 |
About ECO Animal Health
ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.
Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.
Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.
Click here for more information: https://ecoanimalhealth.com